Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA DIVIS LABORATORIES ASTRAZENECA PHARMA/
DIVIS LABORATORIES
 
P/E (TTM) x 95.5 66.0 144.7% View Chart
P/BV x 22.7 7.1 317.6% View Chart
Dividend Yield % 0.3 0.9 34.5%  

Financials

 ASTRAZENECA PHARMA   DIVIS LABORATORIES
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
DIVIS LABORATORIES
Mar-23
ASTRAZENECA PHARMA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3,6204,641 78.0%   
Low Rs2,4382,730 89.3%   
Sales per share (Unadj.) Rs401.2292.6 137.1%  
Earnings per share (Unadj.) Rs39.768.7 57.8%  
Cash flow per share (Unadj.) Rs46.281.6 56.6%  
Dividends per share (Unadj.) Rs16.0030.00 53.3%  
Avg Dividend yield %0.50.8 64.9%  
Book value per share (Unadj.) Rs234.4480.9 48.7%  
Shares outstanding (eoy) m25.00265.47 9.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.512.6 59.9%   
Avg P/E ratio x76.353.7 142.1%  
P/CF ratio (eoy) x65.545.2 145.1%  
Price / Book Value ratio x12.97.7 168.6%  
Dividend payout %40.343.7 92.2%   
Avg Mkt Cap Rs m75,718978,378 7.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,5919,750 26.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,03077,675 12.9%  
Other income Rs m2613,447 7.6%   
Total revenues Rs m10,29181,122 12.7%   
Gross profit Rs m1,24923,691 5.3%  
Depreciation Rs m1633,432 4.7%   
Interest Rs m620 32.1%   
Profit before tax Rs m1,34123,686 5.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3485,453 6.4%   
Profit after tax Rs m99318,234 5.4%  
Gross profit margin %12.530.5 40.8%  
Effective tax rate %26.023.0 112.8%   
Net profit margin %9.923.5 42.2%  
BALANCE SHEET DATA
Current assets Rs m9,35997,437 9.6%   
Current liabilities Rs m4,84415,331 31.6%   
Net working cap to sales %45.0105.7 42.6%  
Current ratio x1.96.4 30.4%  
Inventory Days Days498 590.5%  
Debtors Days Days39842 4.6%  
Net fixed assets Rs m2,06151,128 4.0%   
Share capital Rs m50531 9.4%   
"Free" reserves Rs m5,811127,140 4.6%   
Net worth Rs m5,861127,671 4.6%   
Long term debt Rs m00-   
Total assets Rs m11,421148,565 7.7%  
Interest coverage x213.91,209.5 17.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.5 168.0%   
Return on assets %8.712.3 71.2%  
Return on equity %16.914.3 118.6%  
Return on capital %23.018.6 123.8%  
Exports to sales %085.7 0.0%   
Imports to sales %37.419.8 188.7%   
Exports (fob) Rs mNA66,537 0.0%   
Imports (cif) Rs m3,74715,378 24.4%   
Fx inflow Rs m61266,537 0.9%   
Fx outflow Rs m3,74715,715 23.8%   
Net fx Rs m-3,13550,822 -6.2%   
CASH FLOW
From Operations Rs m58324,597 2.4%  
From Investments Rs m181-27,076 -0.7%  
From Financial Activity Rs m-245-7,972 3.1%  
Net Cashflow Rs m519-10,451 -5.0%  

Share Holding

Indian Promoters % 0.0 51.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 5.4 36.7 14.8%  
FIIs % 2.7 14.9 17.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 48.1 52.0%  
Shareholders   29,032 354,482 8.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on ASTRAZENECA PHARMA vs Divis Laboratories

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Divis Laboratories Share Price Performance

Period ASTRAZENECA PHARMA Divis Laboratories S&P BSE HEALTHCARE
1-Day 0.01% 2.14% 1.18%
1-Month -3.61% -2.15% -0.75%
1-Year 59.20% 22.51% 61.82%
3-Year CAGR 20.50% -1.38% 18.16%
5-Year CAGR 22.18% 15.77% 19.79%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Divis Laboratories share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Divis Laboratories the stake stands at 51.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Divis Laboratories.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

Divis Laboratories paid Rs 30.0, and its dividend payout ratio stood at 43.7%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Divis Laboratories.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.